Kymera Therapeutics, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/6/2026
Shares
21,869
Value ($000)
1,821
Weight
0.0%
2020 Q4 - 2026 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).